Legend Biotech Corporation - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
LEGN Nasdaq 2830 www.legendbiotech.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Legend Biotech Corporation

Legend Biotech Highlights Recent Business Updates at 44th Annual J.P. Morgan Healthcare Conference - Jan 12th, 2026 6:00 am
Does Legend Biotech (LEGN) Offer Value After A 30% One-Year Share Price Decline - Jan 9th, 2026 2:10 pm
Cantor Fitzgerald and RBC Capital Stay Bullish on Legend Biotech (LEGN) - Jan 9th, 2026 10:07 am
Why The Legend Biotech LEGN Story Is Shifting As Carvykti And Competition Reframe Expectations - Jan 9th, 2026 2:11 am
Asian Equities Traded in the US as American Depositary Receipts Rise in Monday Trading - Jan 5th, 2026 8:47 am
Here is Why Legend Biotech (LEGN) Offers Such Promising Upside - Dec 22nd, 2025 4:50 am
Legend Biotech to Present at the 44th Annual J.P. Morgan Healthcare Conference - Dec 17th, 2025 6:00 am
Legend Biotech Corporation (LEGN) is an Outperform on Multiple Myeloma Treatment CARVYKTI Prospects - Dec 11th, 2025 9:26 am
Legend Biotech (NasdaqGS:LEGN): Revisiting Valuation After a Steep Share Price Slide - Dec 10th, 2025 1:12 am
Cancer Study Buoys These Small Biotechs - Dec 9th, 2025 1:31 pm
Legend Biotech Highlights New CARVYKTI® Data in Multiple Myeloma and First-in-Human Results from Novel CAR-T Platform in Non-Hodgkin Lymphoma at ASH 2025 - Dec 6th, 2025 12:00 pm
Legend Biotech Awarded 2025 FIBA Foreign Investor of the Year by Flanders Investment & Trade - Nov 27th, 2025 7:00 am
William Blair Maintains Hold Rating on Legend Biotech (LEGN) Despite Carvykti Label Safety Concerns - Nov 25th, 2025 6:39 am
How Investors Are Reacting To Legend Biotech (LEGN) Opening Its New Philadelphia R&D Center - Nov 14th, 2025 9:12 am
How Recent Developments Are Rewriting the Story for Legend Biotech - Nov 13th, 2025 4:09 pm
Legend Biotech Celebrates Official Opening of New State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia - Nov 13th, 2025 10:08 am
Company News for Nov 13, 2025 - Nov 13th, 2025 7:21 am
Legend Biotech (NasdaqGS:LEGN) Valuation in Focus Following CARVYKTI Sales Surge and Profit Progress - Nov 13th, 2025 7:16 am
Legend Biotech Corp (LEGN) Q3 2025 Earnings Call Highlights: Record CARVYKTI Sales and ... - Nov 12th, 2025 12:03 pm
Legend Biotech Reports Third Quarter 2025 Results and Recent Highlights - Nov 12th, 2025 5:00 am